Cerebral toxoplasmosis in HIV-infected patients: a review.
Dian S, Ganiem AR, Ekawardhani S.
Pathog Glob Health. 2023 Feb;117(1):14-23. doi: 10.1080/20477724.2022.2083977. Epub 2022 Jun 11.
[Toxoplasma encephalitis].
Yamamoto T.
Nihon Naika Gakkai Zasshi. 2006 Jul 10;95(7):1260-2. doi: 10.2169/naika.95.1260.
Advances and Challenges in Understanding Cerebral Toxoplasmosis.
Schlüter D, Barragan A.
Front Immunol. 2019 Feb 14;10:242. doi: 10.3389/fimmu.2019.00242. eCollection 2019.
Central nervous system infection with Toxoplasma gondii.
Marra CM.
Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8.
HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
Vidal JE.
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. doi: 10.1177/2325958219867315.
Toxoplasma encephalitis in HIV-infected person.
Yunihastuti E, Imran D, Sukmana N.
Acta Med Indones. 2005 Jan-Mar;37(1):49-50.
Image Diagnosis: Eccentric Target Sign of Focal Toxoplasma Encephalitis.
Verma S, Singla V, Singh A, Bose A, Pannu AK.
Perm J. 2020;24:19.181. doi: 10.7812/TPP/19.181. Epub 2020 Apr 22.
A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
Almurshidi BH, Fahmy Z, El-Shennawy A, Selim EAH, Hammam OA, Okasha H, Al-Hajj W, Mahmoud SA, Abuelenain GL.
Parasite Immunol. 2023 Dec;45(12):e13014. doi: 10.1111/pim.13014. Epub 2023 Oct 9.
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B.
Medicine (Baltimore). 1992 Jul;71(4):224-39. doi: 10.1097/00005792-199207000-00005.
Toxoplasma gondii and the blood-brain barrier.
Feustel SM, Meissner M, Liesenfeld O.
Virulence. 2012 Mar-Apr;3(2):182-92. doi: 10.4161/viru.19004. Epub 2012 Mar 1.
